- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/50 - Acylated on said nitrogen atom
Patent holdings for IPC class C07D 231/50
Total number of patents in this class: 20
10-year publication summary
|
1
|
4
|
2
|
1
|
3
|
2
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2832 |
11 |
| The Johns Hopkins University | 5825 |
2 |
| The University of Sydney | 625 |
2 |
| Bristol-myers Squibb Company | 4811 |
1 |
| Anagenesis Biotechnologies S.A.S. | 3 |
1 |
| Daiichi Sankyo Company, Limited | 1886 |
1 |
| Hindustan Petroleum Corporation Limited | 223 |
1 |
| Novasaid AB | 9 |
1 |
| Other owners | 0 |